Alps Advisors Inc Procept Bio Robotics Corp Transaction History

Alps Advisors Inc

$17.2 Billion
Q2 2025

A detailed history of Alps Advisors Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Alps Advisors Inc holds 13,669 shares of PRCT stock, worth $474,587. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,669

Previous 14,828 7.82%

Holding current value

$474,587

Previous $863,000 8.81%

% of portfolio

0.0%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$48.82 - $65.05 $56,582 - $75,392	-1,159 Reduced 7.82%	13,669 $787,000
Q1 2025 Apr 30, 2025	BUY	$56.03 - $88.57 $243,898 - $385,545	4,353 Added 41.56%	14,828 $863,000
Q4 2024 Feb 13, 2025	SELL	$67.27 - $99.45 $46,550 - $68,819	-692 Reduced 6.2%	10,475 $843,000
Q3 2024 Nov 12, 2024	SELL	$56.31 - $84.99 $203,279 - $306,813	-3,610 Reduced 24.43%	11,167 $894,000
Q2 2024 Aug 13, 2024	SELL	$45.73 - $69.19 $281,742 - $426,279	-6,161 Reduced 29.42%	14,777 $902,000
Q1 2024 May 14, 2024	SELL	$40.38 - $50.75 $204,322 - $256,795	-5,060 Reduced 19.46%	20,938 $1.03 Million
Q4 2023 Feb 14, 2024	SELL	$24.89 - $43.41 $62,921 - $109,740	-2,528 Reduced 8.86%	25,998 $1.09 Million
Q3 2023 Nov 14, 2023	SELL	$30.02 - $38.81 $120,590 - $155,899	-4,017 Reduced 12.34%	28,526 $935,000
Q2 2023 Aug 14, 2023	SELL	$26.7 - $37.02 $86,187 - $119,500	-3,228 Reduced 9.02%	32,543 $1.15 Million
Q1 2023 May 10, 2023	BUY	$26.64 - $39.74 $253,426 - $378,046	9,513 Added 36.23%	35,771 $1.02 Million
Q4 2022 Feb 14, 2023	BUY	$38.78 - $46.78 $29,395 - $35,459	758 Added 2.97%	26,258 $1.09 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $50.65 $787,950 - $1.29 Million	25,500 New	25,500 $1.06 Million

Others Institutions Holding PRCT

# of Institutions

292

Shares Held

45.2M

Call Options Held

236K

Put Options Held

91.9K

View Full List

About PROCEPT BioRobotics Corp

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $1.55B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

More about PRCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Procept Bio Robotics Corp Transaction History